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Identity 
Other names: ST3 (stromelysin-3); MMP-11 (matrix 
metalloproteinase 11) 




8 exons and 7 introns spanning 11.5 kb; cDNA: 2247 
bp, coding sequence 1464 bp. 
Transcription 
Expression is induced by retinoic acid and TPA 
through a DR1-type responsive element and a C/EBP 
binding site, respectively, expression is induced by 
epithelial cells in a paracrin manner. 
Protein 
Description 
488 amino-acids; 51 kDa; functional domains: signal 
peptide, targeting the protein to the secretory pathway, 
prodomain containing a furin-type cleavage site 
responsible for the intracellular activation, catalytic 
domain containing a zinc binding site, hemopexin-like 
domain. 
Expression 
Cells of mesenchymal origin, notably fibroblastic cells, 
macrophages, osteoclasts. 
Function 
Extracellular zinc-dependent proteinase expressed 
during tissu remodelling processes (development, 
wound healing) and whose specific substrate is 
unknown. 
Homology 
Member of the matrix metalloproteinases (MMP) 




Expression of ST3 in 80 to 100% invasive carcinomas 
of the breast, colon, head and neck, lung, ovary, 
pancreas, prostate, skin (basal cell carcinoma), uterus 
(cervix carcinoma and endometrial carcinoma) and in 
some non-invasive carcinomas that have a high risk of 
evolving towards invasion; also expression in: 
fibroblastic stromal cells in the close vicinity of 
cancerous epithelial cells. 
Prognosis 
Prognostic factor of invasion and aggressiveness of the 
tumors. 
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